Literature DB >> 11585727

A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families.

A Stella1, A Wagner, K Shito, S M Lipkin, P Watson, G Guanti, H T Lynch, R Fodde, B Liu.   

Abstract

Germline mutations in the DNA mismatch repair genes MSH2 and MLH1 are responsible for the majority of hereditary nonpolyposis colorectal cancer (HNPCC) families. A common mutation mechanism is to disrupt MLH1 and MSH2 mRNA splicing. The disruption creates aberrant mRNAs lacking specific coding exons (exon skipping). Here, we report a novel skipping of MLH1 exon 12 caused by an AAG to TAG nonsense mutation at codon 461 in three HNPCC families of North American origins. The nonsense codon was found in a conserved haplotype in the three unrelated families and seems to represent a founder mutation. The skipping created an aberrant MLH1 mRNA transcript lacking exon 12. The effect of the codon 461 nonsense mutation on exon 12 skipping is evident even though it was placed in a minigene construct containing entirely different coding sequences. Notably, the effect of the nonsense mutation on exon skipping is incomplete. Accordingly, a second aberrant MLH1 transcript encompassing the nonsense codon is also produced. Whereas the latter transcript is unstable, presumably because of nonsense-mediated mRNA decay, neither of the aberrant transcripts seems to affect the stability of wild-type MLH1 mRNA. This study demonstrates that the germ-line nonsense mutation at codon 461 of MLH1 disrupts normal MLH1 mRNA processing, and that exon skipping underlies pathogenesis in these HNPCC families.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585727

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome.

Authors:  Michael P Farrell; David J Hughes; Ian R Berry; David J Gallagher; Emily A Glogowski; Stewart J Payne; Michael J Kennedy; Róisín M Clarke; Susan A White; Cian B Muldoon; Fiona Macdonald; Pauline Rehal; Danielle Crompton; Solvig Roring; Sarah T Duke; Trudi McDevitt; David E Barton; Shirley V Hodgson; Andrew J Green; Peter A Daly
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family.

Authors:  S McVety; L Li; P H Gordon; G Chong; W D Foulkes
Journal:  J Med Genet       Date:  2005-05-27       Impact factor: 6.318

3.  Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.

Authors:  Constanze Pagenstecher; Maria Wehner; Waltraut Friedl; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Marlies Sengteller; Wolfram Henn; Reinhard Buettner; Peter Propping; Elisabeth Mangold
Journal:  Hum Genet       Date:  2005-12-08       Impact factor: 4.132

4.  Full-length transcript amplification and sequencing as universal method to test mRNA integrity and biallelic expression in mismatch repair genes.

Authors:  Monika Morak; Kerstin Schaefer; Verena Steinke-Lange; Udo Koehler; Susanne Keinath; Trisari Massdorf; Brigitte Mauracher; Nils Rahner; Jessica Bailey; Christiane Kling; Tanja Haeusser; Andreas Laner; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2019-07-22       Impact factor: 4.246

5.  Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes.

Authors:  Tyler Landrith; Bing Li; Ashley A Cass; Blair R Conner; Holly LaDuca; Danielle B McKenna; Kara N Maxwell; Susan Domchek; Nichole A Morman; Christopher Heinlen; Deborah Wham; Cathryn Koptiuch; Jennie Vagher; Ragene Rivera; Ann Bunnell; Gayle Patel; Jennifer L Geurts; Morgan M Depas; Shraddha Gaonkar; Sara Pirzadeh-Miller; Rebekah Krukenberg; Meredith Seidel; Robert Pilarski; Meagan Farmer; Khateriaa Pyrtel; Kara Milliron; John Lee; Elizabeth Hoodfar; Deepika Nathan; Amanda C Ganzak; Sitao Wu; Huy Vuong; Dong Xu; Aarani Arulmoli; Melissa Parra; Lily Hoang; Bhuvan Molparia; Michele Fennessy; Susanne Fox; Sinead Charpentier; Julia Burdette; Tina Pesaran; Jessica Profato; Brandon Smith; Ginger Haynes; Emily Dalton; Joy Rae-Radecki Crandall; Ruth Baxter; Hsiao-Mei Lu; Brigette Tippin-Davis; Aaron Elliott; Elizabeth Chao; Rachid Karam
Journal:  NPJ Precis Oncol       Date:  2020-02-24

6.  ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

Authors:  Colin C Pritchard; Christina Smith; Stephen J Salipante; Ming K Lee; Anne M Thornton; Alex S Nord; Cassandra Gulden; Sonia S Kupfer; Elizabeth M Swisher; Robin L Bennett; Akiva P Novetsky; Gail P Jarvik; Olufunmilayo I Olopade; Paul J Goodfellow; Mary-Claire King; Jonathan F Tait; Tom Walsh
Journal:  J Mol Diagn       Date:  2012-05-30       Impact factor: 5.568

7.  Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay.

Authors:  Hiromu Naruse; Noriko Ikawa; Kiyoshi Yamaguchi; Yusuke Nakamura; Masami Arai; Chikashi Ishioka; Kokichi Sugano; Kazuo Tamura; Naohiro Tomita; Nagahide Matsubara; Teruhiko Yoshida; Yoshihiro Moriya; Yoichi Furukawa
Journal:  Fam Cancer       Date:  2009-08-15       Impact factor: 2.375

8.  Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Authors:  Anja Wagner; Alicia Barrows; Juul Th Wijnen; Heleen van der Klift; Patrick F Franken; Paul Verkuijlen; Hidewaki Nakagawa; Marjan Geugien; Shantie Jaghmohan-Changur; Cor Breukel; Hanne Meijers-Heijboer; Hans Morreau; Marjo van Puijenbroek; John Burn; Stephany Coronel; Yulia Kinarski; Ross Okimoto; Patrice Watson; Jane F Lynch; Albert de la Chapelle; Henry T Lynch; Riccardo Fodde
Journal:  Am J Hum Genet       Date:  2003-03-25       Impact factor: 11.025

9.  In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects.

Authors:  Patrizia Lastella; Nicoletta Concetta Surdo; Nicoletta Resta; Ginevra Guanti; Alessandro Stella
Journal:  BMC Genomics       Date:  2006-09-22       Impact factor: 3.969

Review 10.  Exon identity crisis: disease-causing mutations that disrupt the splicing code.

Authors:  Timothy Sterne-Weiler; Jeremy R Sanford
Journal:  Genome Biol       Date:  2014-01-23       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.